stockportfolio.pro
CeriBell, Inc. (CBLL)
Healthcare · Medical Devices · NasdaqGS
CeriBell, Inc. revenue & earnings — last 4 fiscal years
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $25.92M | $45.23M | $65.44M | $89.06M |
| Gross profit | $21.49M | $38.16M | $56.75M | $78.27M |
| Net income | $-37.16M | $-29.46M | $-40.45M | $-53.41M |
| Net margin | -143.4% | -65.1% | -61.8% | -60.0% |
Source: CeriBell, Inc. SEC filings (10-K).
Explore 4 years of CeriBell, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track CBLL in your portfolio →
CeriBell, Inc. financial history by metric
About CeriBell, Inc.
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
CeriBell, Inc. — frequently asked questions
What is CeriBell, Inc.'s revenue?
CeriBell, Inc. (CBLL) reported revenue of $89.06M for fiscal year 2025, up 36.1% from the prior year, according to its SEC filings.
Is CeriBell, Inc. profitable?
No — CBLL reported a net loss of $-53.41M in fiscal 2025.
What is CBLL's P/E ratio?
CeriBell, Inc. trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How fast is CeriBell, Inc. growing?
CBLL's revenue grew at roughly 50.9% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does CeriBell, Inc. have?
As of fiscal year 2025, CBLL carried roughly $19.81M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is CeriBell, Inc.'s gross margin?
CBLL's gross margin was 87.9% in fiscal 2025 — gross profit of $78.27M on revenue of $89.06M.
What is CeriBell, Inc.'s market cap?
CeriBell, Inc. (CBLL) has a market capitalization of about $683.54M, based on the latest data in our nightly-refreshed cache.
When does CeriBell, Inc.'s fiscal year end?
CBLL's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
Where does this data come from?
All figures are computed from CeriBell, Inc.'s official SEC filings (10-K and 10-Q), covering 4 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.